Action of Cannabidiol on the Anxiety and Other Effects Produced by Delta 9-THC in Normal Subjects
Overview
Authors
Affiliations
The object of the experiment was to verify whether cannabidiol (CBD) reduces the anxiety provoked by delta 9-THC in normal volunteers, and whether this effect occurs by a general block of the action of delta 9-THC or by a specific anxiolytic effect. Appropriate measurements and scales were utilized and the eight volunteers received, the following treatments in a double-blind procedure: 0.5 mg/kg delta 9-THC, 1 mg/kg CBD, a mixture containing 0.5 mg/kg delta 9-THC and 1 mg/kg CBD and placebo and diazepam (10 mg) as controls. Each volunteer received the treatments in a different sequence. It was verified that CBD blocks the anxiety provoked by delta 9-THC, however this effect also extended to marihuana-like effects and to other subjective alterations induced by delta 9-THC. This antagonism does not appear to be caused by a general block of delta 9-THC effects, since no change was detected in the pulse-rate measurements. Several further effects were observed typical of CBD and of an opposite nature to those of delta 9-THC. These results suggest that the effects of CBD, as opposed to those of delta 9-THC, might be involved in the antagonism of effects between the two cannabinoids.
Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment.
Taudul J, Celej J, Zelechowska-Matysiak K, Kepinska D, Majkowska-Pilip A, Strawski M Biomolecules. 2025; 15(2).
PMID: 40001533 PMC: 11853022. DOI: 10.3390/biom15020230.
Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims.
Engeli B, Lachenmeier D, Diel P, Guth S, Villar Fernandez M, Roth A Nutrients. 2025; 17(3).
PMID: 39940347 PMC: 11820564. DOI: 10.3390/nu17030489.
Oral cannabidiol did not impair learning and memory in healthy adults.
Gebregzi H, Zeiger J, Smith J, Stuyt L, Cullen L, Carsella J J Cannabis Res. 2025; 7(1):5.
PMID: 39849639 PMC: 11756171. DOI: 10.1186/s42238-025-00262-2.
Potential Risks from Cannabis-Infused Beverages: A Critical Review.
Froude A, Pangborn N, Britz-McKibbin P, MacKillop J, Balodis I Cannabis. 2025; 7(3):134-166.
PMID: 39781553 PMC: 11705039. DOI: 10.26828/cannabis/2024/000271.
Simei J, Souza J, Pedrazzi J, Guimaraes F, Campos A, Zuardi A Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770486 PMC: 11677192. DOI: 10.3390/ph17121644.